REPLIGEN CORP (RGEN) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2009: $5.04M2010: $9.79M2011: $11.17M2012: $29.21M2013: $39.83M2014: $35.36M2015: $54.09M2016: $122.23M2017: $173.76M2018: $193.82M2019: $528.39M2020: $717.29M2021: $603.81M2022: $523.46M2023: $751.32M2024: $757.36M2025: $566.02M$566.02M
2009Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$566.02M-25.3%
2024$757.36M+0.8%
2023$751.32M+43.5%
2022$523.46M-13.3%
2021$603.81M-15.8%
2020$717.29M+35.7%
2019$528.39M+172.6%
2018$193.82M+11.5%
2017$173.76M+42.2%
2016$122.23M+126.0%
2015$54.09M+53.0%
2014$35.36M-11.2%
2013$39.83M+36.4%
2012$29.21M+161.6%
2011$11.17M+14.0%
2010$9.79M+94.3%
2009$5.04M